Tanvex BioPharma, Inc. (TPE:6541)

Tanvex BioPharma Revenue

Tanvex BioPharma had revenue of 46.82M TWD in the quarter ending June 30, 2025, with 175.28% growth. This brings the company's revenue in the last twelve months to 110.99M, up 221.19% year-over-year. In the year 2024, Tanvex BioPharma had annual revenue of 34.68M, down -43.53%.

• Revenue (ttm): 110.99M
• Revenue Growth: +221.19%
• P/S Ratio: 111.39
• Revenue / Employee: n/a
• Employees: 200
• Market Cap: 12.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.68M	-26.73M	-43.53%
Dec 31, 2023	61.41M	39.01M	174.11%
Dec 31, 2022	22.40M	17.00M	314.43%
Dec 31, 2021	5.41M	5.11M	1,702.00%
Dec 31, 2020	300.00K	-	-